Ledipasvir And Sofosbuvir 72626-2601-01
- Manufacturer
- Asegua Therapeutics Llc
- Dosage Form
- Tablet, Film Coated
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- January 1, 2019
- Listing Expires
- December 31, 2026
- Application
- NDA205834
Need to source Ledipasvir And Sofosbuvir? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Ledipasvir | 90 mg/1 |
| Sofosbuvir | 400 mg/1 |
Drug Class
Hepatitis C Virus NS5A Inhibitor [EPC]Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC]Breast Cancer Resistance Protein Inhibitors [MoA]
Selected Package
72626-2601-01Selected2 BLISTER PACK in 1 CARTON (72626-2601-1) / 14 TABLET, FILM COATED in 1 BLISTER PACK